Repeat head computed tomography for anticoagulated patients with an initial negative scan is not cost-effective

Patients on antithrombotic medications presenting with blunt trauma are at risk for delayed intracranial hemorrhage. We hypothesized that clinically significant delayed intracranial hemorrhage is rare in patients presenting on antithrombotic medications and therefore routine, repeat head computed tomography imaging is not a cost-effective practice to monitor for delayed intracranial hemorrhage.

Source: Surgery - March 26, 2021 Category: Surgery Authors: Johanna Borst, Laura N. Godat, Allison E. Berndtson, Leslie Kobayashi, Jay J. Doucet, Todd W. Costantini Source Type: research